Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics

BACKGROUND: Alzheimer’s disease (AD) is the leading cause of dementia affecting greater than 26 million people worldwide. Although cerebrospinal fluid (CSF) levels of Aβ(42), tau, and p-tau(181) are well established as diagnostic biomarkers of AD, there is a need for additional CSF biomarkers of neu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wildsmith, Kristin R, Schauer, Stephen P, Smith, Ashley M, Arnott, David, Zhu, Yuda, Haznedar, Joshua, Kaur, Surinder, Mathews, W Rodney, Honigberg, Lee A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061120/
https://www.ncbi.nlm.nih.gov/pubmed/24902845
http://dx.doi.org/10.1186/1750-1326-9-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061120/
https://www.ncbi.nlm.nih.gov/pubmed/24902845
http://dx.doi.org/10.1186/1750-1326-9-22

Ejemplares similares